Cardiac Coherence Training to Reduce Anxiety in Remitted Schizophrenia, a Pilot Study

M Trousselard, F Canini, D Claverie, C Cungi, B Putois, N Franck, M Trousselard, F Canini, D Claverie, C Cungi, B Putois, N Franck

Abstract

Health care that addresses the emotional regulation capacity of patients with schizophrenia confronted with daily stress may contribute to a less anxious life. A psycho-physiological training [cardiac coherence training (CCT)] focusing on emotion regulation is known to decrease anxiety for healthy individuals. We performed a pilot cross sectional survey to explore the benefits of CCT for clinically stable patients with schizophrenia. Ten patients were enrolled in the program consisting of twelve weekly 1-h session programs monitored over a 2-month period. Standardised questionnaires were used before and after the intervention to assess anxiety, well-being outcomes, and how patients deal with stress and stressors. Results showed that this quite-well accepted intervention improved (or tended to improve) well-being outcomes, state-anxiety, and emotional stressors evaluation. The successful transformations were higher for patients with the highest clinical and emotional suffering. Thus, this pilot study revealed that CCT may help patients with schizophrenia to deal with anxiety in daily life.

Keywords: Anxiety; Emotional regulation; No drug therapy; Schizophrenia; Well-being.

Conflict of interest statement

Compliance with Ethical Standards Conflict of interest The authors declare that there are no competing interests.

Figures

Fig. 1
Fig. 1
Evolution of the assessed outcomes’ scores for the GNO and GPO after the CCT. *indicating a significant difference (p < .05)

References

    1. Abdi H, Williams LJ. Principal component analysis. Wiley Interdisciplinary Reviews: Computational Statistics. 2010;2:433–459. doi: 10.1002/wics.101.
    1. Achim A, Maziade M, Raymond E, Olivier D, Mérette C, Roy MA. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophrenia Bulletin. 2011;37(4):811–821. doi: 10.1093/schbul/sbp148.
    1. Aleman A, Kahn RS. Strange feelings: Do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Progress in Neurobiology. 2005;77:283–298.
    1. Barrios F, McCraty R, et al. An inner quality approach to reducing stress and improving physical and emotional well-being at work. Stress Medicine. 1997;13(3):193–201. doi: 10.1002/(SICI)1099-1700(199707)13:3<193::AID-SMI744>;2-I.
    1. Bennett MR. Stress and anxiety in schizophrenia and depression: glucocorticoids, corticotropin-releasing hormone and synapse regression. Australian and New Zealand Journal of Psychiatry. 2008;42:995–1002. doi: 10.1080/00048670802512073.
    1. Berger S, Boettger MK, Tancer M, Guinjoan SM, Yeragani VK, Bär KJ. Reduced cardio-respiratory coupling indicates suppression of vagal activity in healthy relatives of patients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2010;34(2):406–411. doi: 10.1016/j.pnpbp.2010.01.009.
    1. Betensky JD, Robinson DG, Gunduz-Bruce H, Sevy S, Lencz T, Kane JM, Malhotra AK, Miller R, McCormack J, Bilder RM, Szeszko PR. Patterns of stress in schizophrenia. Psychiatry Research. 2008;160(1):38–46. doi: 10.1016/j.psychres.2007.06.001.
    1. Borod JC, Martin CC, Alpert M, Brozgold A, Welkowitz J. Perception of facial emotion in schizophrenic and right brain-damaged patients. Journal of Nervous and Mental Disease. 1993;181:494–502. doi: 10.1097/00005053-199308000-00004.
    1. Braga RJ, Mendlowicz MV, Marrocos RP, Figueira IL. Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life. Journal of Psychiatric Research. 2005;39:409–414. doi: 10.1016/j.jpsychires.2004.09.003.
    1. Braga RJ, Petrides G, Figueira IL. Anxiety disorders in schizophrenia. Comprehensive Psychiatry. 2004;45(6):460–468. doi: 10.1016/j.comppsych.2004.07.009.
    1. Bruchon-Schweitzer, M., & Paulhan, I. (1993). Inventaire d’anxiété état-trait forme Y (STAI-Y): Adaptation française. Paris: Les Éditions du Centre de Psychologie Appliquée.
    1. Butzlaff RL, Hooley JM. Expressed emotion and psychiatric relapse. Archives of General Psychiatry. 1998;55:547–552. doi: 10.1001/archpsyc.55.6.547.
    1. Chen WC, Chu H, et al. Efficacy of progressive muscle relaxation training in reducing anxiety in patients with acute schizophrenia. Journal of Clinical Nursing. 2009;18:2187–2196. doi: 10.1111/j.1365-2702.2008.02773.x.
    1. Corcoran C, Walker E, Huot R, Mittal V, Tessner K, Kestler L, Malaspina D. The stress cascade and schizophrenia: Etiology and onset. Schizophrenia Bulletin. 2003;29:671–692. doi: 10.1093/oxfordjournals.schbul.a007038.
    1. Craig AD. The sentient self. Brain Structure and Function. 2010;214(5–6):563–577. doi: 10.1007/s00429-010-0248-y.
    1. David AS, Buchanan A, Reed A, Almeida O. The assessment of insight in psychosis. The British Journal of Psychiatry. 1992;161(5):599–602. doi: 10.1192/bjp.161.5.599.
    1. Davis LW, Strasburger AM, Brown LF. Mindfulness: An intervention for anxiety in schizophrenia. Journal of Psychosocial Nursing and Mental Health Services. 2007;45(11):23–29.
    1. DeLongis A, Coyne JC, Dakof G, Folkman S, Lazarus RS. Relationship of daily hassles, upfits, and major life events to health status. Health Psychology. 1982;1:119–136. doi: 10.1037/0278-6133.1.2.119.
    1. Derogatis LR. The Derogatis stress profile (DSP): Quantification of psychological stress. Advances in Psychosomatic Medicine. 1987;17:30–54. doi: 10.1159/000414005.
    1. Dohrenwend BP, Egri G. Recent stressful life events and episodes of schizophrenia. Schizophrenia Bulletin. 1981;7(1):12–23. doi: 10.1093/schbul/7.1.12.
    1. Duncan GE, Sheitman BB, Lieberman JA. An integrated view of pathophysiological models of schizophrenia. Brain Research Reviews. 1999;29:250–264. doi: 10.1016/S0165-0173(99)00002-8.
    1. Falloon IRH, McGill CW. Family stress and the course of schizophrenia: A review. In: Falloon IRH, editor. Family management of schizophrenia: A study of clinical, social, family and economic benefits. New York: Guilford Press; 1985. pp. 1–22.
    1. Fowles D. Schizophrenia: Diathesis-stress revisited. Annual Review of Psychology. 1992;43:303–336. doi: 10.1146/annurev.ps.43.020192.001511.
    1. Franck N, Farrer C, Georgieff N, Marie-Cardine M, Daléry J, d’Amato T, Jeannerod M. Defective recognition of one’s own actions in patients with schizophrenia. American Journal of Psychiatry. 2001;158:454–459. doi: 10.1176/appi.ajp.158.3.454.
    1. Frith CD, Blakemore SJ, Wolpert DM. Explaining the symptoms of schizophrenia: Abnormalities in the awareness of action. Brain Research Reviews. 2000;31:357–363. doi: 10.1016/S0165-0173(99)00052-1.
    1. Gilleen J, Greenwood K, David AS. Domains of awareness in schizophrenia. Schizophrenia Bulletin. 2011;37(1):61–72. doi: 10.1093/schbul/sbq100.
    1. Goodwin RD, Amador T. Anxiety and substance use comorbidity among inpatients with schizophrenia. Schizophrenia Research. 2003;61:89–95. doi: 10.1016/S0920-9964(02)00292-X.
    1. Grant I, Gerst M, Yager J. Scaling of life events by psychiatric patients and normals. Journal of Psychosomatic Research. 1976;20:141–149. doi: 10.1016/0022-3999(76)90041-6.
    1. Guelfi JD. L’échelle PANSS (The PANSS scale) Encéphale. 1997;23(2):35–38.
    1. Hooker C, Park S. Emotion processing and its relationship to social functioning in schizophrenic patients. Psychiatry Research. 2002;112:41–50. doi: 10.1016/S0165-1781(02)00177-4.
    1. Horan WP, Blanchard JJ. Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping. Schizophrenia Research. 2003;60(2):271–283. doi: 10.1016/S0920-9964(02)00227-X.
    1. Horan WP, Ventura J, Nuechterlein KH, Subotnik KL, Hwang SS, Mintz J. Stressful life events in recent-onset schizophrenia: Reduced frequencies and altered subjective appraisal. Schizophrenia Research. 2005;75:363–374. doi: 10.1016/j.schres.2004.07.019.
    1. Huppert JD, Weiss KA, Lim R, Pratt S, Smith TE. Quality of life in schizophrenia: contributions of anxiety and depression. Schizophrenia Research. 2001;51:171–180. doi: 10.1016/S0920-9964(99)00151-6.
    1. Kanner AP, Coyne JC, Schaefer C, Lazarus RS. Comparison of two modes of stress measurements: daily hassles and uplifts versus major events. Journal of Behavioral Medicine. 1981;4:1–39. doi: 10.1007/BF00844845.
    1. Karatzias T, Gumley A, Power K, O’Grady M. Illness appraisals and self-esteem as correlates of anxiety and affective comorbid disorders in schizophrenia. Comprehensive Psychiatry. 2007;48:371–375. doi: 10.1016/j.comppsych.2007.02.005.
    1. Kay SR, Fiszbein A, Lewis A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 1987;13(2):261–276. doi: 10.1093/schbul/13.2.261.
    1. Kohls N, Sauer S, Walach H. Facets of mindfulness: Results of an online study investigating the freiburg mindfulness inventory. Personality and Individual Differences. 2009;46:224–230. doi: 10.1016/j.paid.2008.10.009.
    1. Kring AM, Earnst KS. Stability of emotional responding in schizophrenia. Behavior Therapy. 1999;30:373–388. doi: 10.1016/S0005-7894(99)80016-1.
    1. Kring AM, Neale JM. Do schizophrenics show a disjunctive relationship among expressive, experiential, and psychophysiological components of emotion? Journal of Abnormal Psychology. 1996;105:249–257. doi: 10.1037/0021-843X.105.2.249.
    1. Lecrubier Y, Sheehan D, Weiller E, Amorin P, Bonora I, Sheehan K, Janavs J, Dunbar G. The Mini International Neuropsychiatric Interview (M.I.N.I.). A short diagnostic interview: Reliability and validity according to the CIDI. European Psychiatry. 1997;12:232–241. doi: 10.1016/S0924-9338(97)83296-8.
    1. Lewis DA, Lieberman JA. Catching up on schizophrenia: Natural history and neurobiology. Neuron. 2000;28:325–334. doi: 10.1016/S0896-6273(00)00111-2.
    1. Luskin F, Reitz M, Newell K, Quinn TG, Haskell W. A controlled pilot study of stress management training in ederly patients with congestive heart fealure. Preventive Cardiology. 2002;5(4):168–172. doi: 10.1111/j.1520.037X.2002.01029.x.
    1. Lysaker PH, Salyers MP. Anxiety symptoms in schizophrenia spectrum disorders: Associations with social function, positive and negative symptoms, hope and trauma history. Acta Psychiatrica Scandinavica. 2007;116:290–298. doi: 10.1111/j.1600-0447.2007.01067.x.
    1. Lysaker PH, Yanos PT, Outcalt J, Roe D. Association of stigma, self-Esteem, and symptoms with concurrent and prospective assessment of social anxiety in schizophrenia. Clinical Schizophrenia & Related Psychoses. 2010;4(1):41–48. doi: 10.3371/CSRP.4.1.3.
    1. McCraty R, editor. Science of the heart: Exploring the role of the heart in the human performance. Boulder Creek, CA: Institute of Heartmath; 2001.
    1. McCraty R, Atkinson M, Tiller WA, Rein G, Watkins AD. The effects of emotions on short term heart rate variability using power spectrum analysis. American Journal of Cardiology. 1995;76:1089–1093. doi: 10.1016/S0002-9149(99)80309-9.
    1. McCraty R, Barrios-Choplin B, Rozman D, Atkinson M, Watkins AD. The impact of a new emotional self-management on stress, emotions, heart rate variability, DHEA and cortisol. Integrative Physiological and Behavioral Science. 1998;33(2):151–170. doi: 10.1007/BF02688660.
    1. Montgomery C, Bujold N, Bertrand R, Dupuis F. Étude des caractéristiques psychométriques des indicateurs de stress et de la résolution de problèmes sociaux chez les stagiaires en enseignement. Revue canadienne de l’enseignement supérieur. 2002;32(1):57–90.
    1. Mortimer AM. Symptom rating scales and outcome in schizophrenia. The British Journal of Psychiatry. 2007;191(50):7–14. doi: 10.1192/bjp.191.50.s7.
    1. Nicholson IR, Neufeld WJ. A dynamic vulnerability perspective on stress and schizophrenia. American Journal of Orthopsychiatry. 1992;62(1):117–130. doi: 10.1037/h0079307.
    1. Norman RM, Malla AK. Stressful life events and schizophrenia. I: A review of the research. The British Journal of Psychiatry. 1993;162:161–166. doi: 10.1192/bjp.162.2.161.
    1. Norman RM, Malla AK. A prospective study of daily stressors and symptomatology in schizophrenic patients. Social Psychiatry and Psychiatric Epidemiology. 1994;29(6):244–249. doi: 10.1007/BF00802047.
    1. Nuechterlein KH, Dawson ME. A heuristic vulnerability-stress model of schizophrenic episodes. Schizophrenia Bulletin. 1984;10:300–312. doi: 10.1093/schbul/10.2.300.
    1. Nuechterlein KH, Dawson ME, Gitlin M, Ventura J, Goldstein MJ, Snyder KS, et al. Developmental processes in schizophrenic disorders: Longitudinal studies of vulnerability and stress. Schizophrenia Bulletin. 1992;18:387–425. doi: 10.1093/schbul/18.3.387.
    1. Palaniyappan L, Mallikarjun P, Joseph V, Liddle Peter F. Appreciating symptoms and deficits in schizophrenia: Right posterior insula and poor insight. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2011;35:523–527. doi: 10.1016/j.pnpbp.2010.12.008.
    1. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT. Neurobiology of schizophrenia. Neuron. 2006;52(1):139–153. doi: 10.1016/j.neuron.2006.09.015.
    1. Spielberger CD. Anxiety: state-trait process. In: Spielberger CD, Sarason IG, editors. Stress and anxiety. New York: Wiley; 1975. pp. 115–143.
    1. Spielberger CD. Manual for state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
    1. Starkey D, Deleone H, Flannery RB. Stress management for psychiatric patients in a state hospital setting. American Journal of Orthopsychiatry. 1995;65:446–450. doi: 10.1037/h0079698.
    1. Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Weich S, Parkinson J, Secker J, Stewart-Brown S. The Warwick–Edinburgh mental well-being scale (WEMWBS): Development and UK validation. Health and Quality of life Outcomes. 2007;5:63. doi: 10.1186/1477-7525-5-63.
    1. Townsend MH, Baier MB, et al. Blood pressure, heart rate, and anxiety in schizophrenia. Psychiatry Research. 2007;151:155–157. doi: 10.1016/j.psychres.2006.09.002.
    1. Trousselard, M., Steiler, D., Dutheil, F., Claverie, D., Canini, F., Naughton, G., Stewart-Brown, S., & Franck, N. (in revision). Validation of the Warwick–Edinburgh mental well-being Scale (WEMWBS) in French psychiatric and general populations. Health Qual Life Outcomes.
    1. Trousselard M, Steiler D, Raphel C, Cian C, Duymedjian R, Claverie D, Canini F. Validation of a French version of the Freiburg Mindfulness Inventory-short version: Relationships between mindfulness and stress in an adult population. BioPsychosocial Medicine. 2010;4:1–11. doi: 10.1186/1751-0759-4-8.
    1. Vancampfort D, de Hert M, Knapen J, Wampers M, Demunter H, Deckx S, Maurissen K, Probst M. State anxiety, psychological stress and positive well-being responses to yoga and aerobic exercise in people with schizophrenia: a pilot study. Disability and Rehabilitation. 2011;33(8):684–689. doi: 10.3109/09638288.2010.509458.
    1. Ventura J, Nuechterlein KH, Lukoff D, Hardesty JP. A prospective study of stressful life events and schizophrenic relapse. Journal of Abnormal Psychology. 1989;98:407–411. doi: 10.1037/0021-843X.98.4.407.
    1. Walach H, Buchheld N, Buttenmüller V, Kleinknecht N, Schmidt S. Measuring mindfulness: The Freiburg mindfulness inventory (FMI) Personality and Individual Differences. 2006;40:1543–1555. doi: 10.1016/j.paid.2005.11.025.
    1. Walker E, Kestler L, Bollini A, Hochman KM. Schizophrenia: Etiology and course. Annual Review of Psychology. 2004;55:401–430. doi: 10.1146/annurev.psych.55.090902.141950.
    1. Walker E, McGuire M, Bettes B. Recognition and identification of facial stimuli by schizophrenics and patients with affective disorders. British Journal of Clinical Psychology. 1984;23:37–44. doi: 10.1111/j.2044-8260.1984.tb00624.x.
    1. Wittmann M, Simmons AN, Aron JL, Paulus MP. Accumulation of neural activity in the posterior insula encodes the passage of time. Neuropsychologia. 2010;48(10):3110–3120. doi: 10.1016/j.neuropsychologia.2010.06.023.
    1. Zuroff DC, Colussy SA. Emotional recognition in schizophrenia and depressed inpatients. Journal of Clinical Psychology. 1986;42:411–416. doi: 10.1002/1097-4679(198605)42:3<411::AID-JCLP2270420302>;2-T.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren